| 000 | 01750 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516060829.0 | ||
| 264 | 0 | _c20120216 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1945-7170 | ||
| 024 | 7 |
_a10.1210/en.2011-1056 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGravina, Giovanni Luca | |
| 245 | 0 | 0 |
_aHormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. _h[electronic resource] |
| 260 |
_bEndocrinology _cDec 2011 |
||
| 300 |
_a4550-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnilides _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferases _xgenetics |
| 650 | 0 | 4 | _aDNA Methyltransferase 3A |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aEpigenomics |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHormones _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTosyl Compounds _xpharmacology |
| 650 | 0 | 4 | _aDNA Methyltransferase 3B |
| 700 | 1 | _aMarampon, Francesco | |
| 700 | 1 | _aPiccolella, Margherita | |
| 700 | 1 | _aMotta, Marcella | |
| 700 | 1 | _aVentura, Luca | |
| 700 | 1 | _aPomante, Roberto | |
| 700 | 1 | _aPopov, Vladimir M | |
| 700 | 1 | _aZani, Bianca M | |
| 700 | 1 | _aPestell, Richard G | |
| 700 | 1 | _aTombolini, Vincenzo | |
| 700 | 1 | _aJannini, Emmanuele A | |
| 700 | 1 | _aFestuccia, Claudio | |
| 773 | 0 |
_tEndocrinology _gvol. 152 _gno. 12 _gp. 4550-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2011-1056 _zAvailable from publisher's website |
| 999 |
_c21223665 _d21223665 |
||